Ma et al. [46] examining cardiomyopathy in mice, found that blocking TLR2 activity blunted cardiac dysfunction and inhibited cardiac fibrosis, whereas blocking TLR4 exacerbated cardiac dysfunction and fibrosis. The gene discussed is TLR4; the disease is cardiomyopathy.